Document is current
Any future updates will be listed below
-
Authors
Bezbradica, Jelena S https://orcid.org/0000-0003-1441-1727
Bryant, Clare E https://orcid.org/0000-0002-2924-0038
-
Funding
Funding for this research was provided by:
UKRI | Medical Research Council (MR/W001217/1)
UKRI | MRC | Medical Research Foundation (MR/X000826/1)
Kennedy Trust for Rheumatology Research (KENN20 21 13)
- License Information
-
More Information
Article History
Received: 28 August 2023
Revised: 25 October 2023
Accepted: 10 November 2023
First Online: 15 December 2023
Disclosure and competing interests statement
: CEB is a founder of Polypharmakos and Danger Bio, on the scientific advisory board of NodThera, Lightcast and Related Sciences and a consultant to Janssen. JSB has no conflicts to declare.
